Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: Association with pretransplant psychosocial factors and perceptions of health status change

Progress in Transplantation

Volumn 23, Issue 4, 2013, Pages 319-328

  Rodrigue, James ^a   Nelson, David ^b   Hanto, Douglas ^c   Reed, Alan ^d   Curry, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADAPTIVE BEHAVIOR; ADDICTION; ADULT; ARTICLE; FEMALE; HEALTH STATUS; HUMAN; LIVER TRANSPLANTATION; MALE; MEDICATION COMPLIANCE; MENTAL HEALTH; MIDDLE AGED; MOOD DISORDER; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; RISK FACTOR; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICAL MODEL; UNITED STATES; CLINICAL TRIAL; PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; FEMALE; FLORIDA; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MASSACHUSETTS; MEDICATION ADHERENCE; MENTAL HEALTH; MIDDLE AGED; MOOD DISORDERS; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84890101125     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/pit2013501     Document Type: Article

References (50)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 annual data report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. Am J Transplant. 2012;12(suppl):53-74.
2. Butt Z, Parikh ND, Skaro AI, Ladner D, Cella D. Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research. Curr Opin Organ Transplant. 2012;17(3):241-247.
3. Morrissey PE, Flynn ML, Lin S. Medication noncompliance and its implications in transplant recipients. Drugs. 2007;67(10):1463-1481.
4. Kaul V, Khurana S, Munoz S. Management of medication noncompliance in solid-organ transplant recipients. BioDrugs. 2000;13(5):313-326.
5. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9(11):2597-2606.
6. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77(5):769-776.
7. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7): 858-873.
8. Widows M, Rodrigue JR. Clinical practice issues in solid organ transplantation. In: Llewelyn S, Kennedy P, eds. Handbook of Clinical Health Psychology. Oxford, United Kingdom: John Wiley and Sons; 2003:277-301.
9. Flamme NE, Terry CL, Helft PR. The influence of psychosocial evaluation on candidacy for liver transplantation. Prog Transplant. 2008;18(2):89-96.
10. Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics. 1993;34(4):314-323.
11. Olbrisch ME, Benedict SM, Ashe K, Levenson JL. Psychological assessment and care of organ transplant patients. J Consult Clin Psychol. 2002;70(3):771-783.
12. Sabate E. World Health Organization Report: Adherence to Long-Term Therapies. Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
13. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
14. Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation. 2000;70(5):711-716.
15. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and metaanalysis. J Acquir Immune Defic Syndr. 2011;58(2):181-187.
16. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398-2403.
17. Dempe C, J?ger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res. 2013;74(2):122-127.
18. Bautista LE, Vera-Cala LM, Colombo C, Smith P. Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens. 2012;25(4):505-511.
19. Osborn CY, Egede LE. The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012;34(3): 249-253.
20. Scheurer D, Choudhry N, Swanton KA, Matlin O, Shrank W. Association between different types of social support and medication adherence. Am J Manag Care. 2012;18(12):e461-e467.
21. Vyavaharkar M, Moneyham L, Tavakoli A, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDS. 2007;21(9):667-680.
22. Grodensky CA, Golin CE, Ochtera RD, Turner BJ. Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. J Stud Alcohol Drugs. 2012;73(6):899-910.
23. Power R, Koopman C, Volk J, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care STDS. 2003;17(5):245-252.
24. Lisson GL, Rodrigue JR, Reed AI, Nelson DR. A brief psychological intervention to improve adherence following transplantation. Ann Transpl. 2005;10(1):52-57.
25. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87(10):1497-1504.
26. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15(6):631-645.
27. Drent G, Haagsma EB, Geest SD, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int. 2005;18(8):960-966.
28. Kung M, Koschwanez HE, Painter L, Honeyman V, Broadbent E. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Transplantation. 2012;93(9):958-963.
29. De Bleser L, Dobbels F, Berben L, et al. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. Transpl Int. 2011;24(9): 882-891.
30. Scholz U, Klaghofer R, Dux R, et al. Predicting intentions and adherence behavior in the context of organ transplantation: gender differences of provided social support. J Psychosom Res. 2012;72(3):214-219.
31. Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transplant. 2010;20(1):58-66.
32. Burra P, Germani G, Gnoato F, et al. Adherence in liver transplant recipients. Liver Transpl. 2011;17(7):760-770.
33. Telles-Correia D, Barbosa A, Mega I, Monteiro E. Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal. Prog Transplant. 2012;22(1):91-94.
34. Morales JM, Varo E, L?aro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transplant. 2012; 26(2):369-376.
35. Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transplant. 2012;26(2):328-335.
36. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation. 1990;49(2):374-377.
37. O'Carroll RE, McGregor LM, Swanson V, Masterton G, Hayes PC. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl. 2006;12(12):1862-1868.
38. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant. 2009;9(1):35-41.
39. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioner's Guidebook. New York, NY: Plenum Press; 1987.
40. Ortego C, Huedo-Medina TB, Santos P, et al. Sex differences in adherence to highly active antiretroviral therapy: a metaanalysis [Epub ahead of print]. AIDS Care. 2012;24(12):1519-1534.
41. Khan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke. 2010;41(7):1445-1449.
42. Nau DP, Aikens JE, Pacholski AM. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med. 2007;4(3):205-213.
43. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223-1229.
44. Bautista LE, Vera-Cala LM, Colombo C, Smith P. Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens. 2012;25(4):505-511.
45. Wagner GJ, Goggin K, Remien RH, et al; MACH14 Investigators. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med. 2011;42(3):352-360.
46. Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011; 26(10):1175-1182.
47. Chisholm-Burns MA, Spivey CA, Wilks SE. Social support and immunosuppressant therapy adherence among adult renal transplant recipients. Clin Transplant. 2010;24(3):312-320.
48. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207-218.
49. Cohen M, Katz D, Baruch Y. Stress among the family caregivers of liver transplant recipients. Prog Transplant. 2007;17(1):48-53.
50. Rodrigue JR, Dimitri N, Reed A, Antonellis T, Hanto DW, Curry M. Quality of life and psychosocial functioning of spouse/partner caregivers before and after liver transplantation. Clin Transplant. 2011;25(2):239-247.